Consensus Oramed Pharmaceuticals Inc.

Equities

ORMP

US68403P2039

Real-time Estimate Cboe BZX 11:58:32 2024-03-28 am EDT 5-day change 1st Jan Change
2.985 USD +5.85% Intraday chart for Oramed Pharmaceuticals Inc. +5.71% +28.14%

Evolution of the average Target Price on Oramed Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

f.IDeXYbLZl6uK3OlkHhkk173P5NzvHpHm9iJg_GRN0R8.FRrGUcCp48HZuaIlRkhq5sqotOSbbf-vu24ynlAr6VoYf99Xy5Oj_73spA~e8389626e7700c7e84a721266dda6caa

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.82 USD
Average target price
4.25 USD
Spread / Average Target
+50.71%
High Price Target
4.25 USD
Spread / Highest target
+50.71%
Low Price Target
4.25 USD
Spread / Lowest Target
+50.71%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Oramed Pharmaceuticals Inc.

Canaccord Genuity
HC Wainwright
Cantor Fitzgerald
Aegis Capital
National Securities
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings